CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

SBI Healthcare Opp Fund-Reg(G)

very highequitypharma & health care
422.09 6.90(1.66%) NAV as on 04 Feb 2025
-4.14 % 1 M
29.31 % 1 Y
23.55 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.94

As on 31 Dec, 2024
age-icon Age :

25 yrs 6 m

Since 14 07 ,1999
exit_load Exit Load :

0.5%

aum AUM :

3,628.03 Crs

lock_in Lock-in :

0.50% on or before 15D, Nil after 15D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.24

Min_Investment Min. Investment :

SIP 500 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Tanmaya Desai,Pradeep Kesavan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Dec 31 ,2024
Debt 0.08 %
Others 3.35 %
Equity 96.57 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.00 %
Max Healthcare Institute Ltd.6.22 %
Divi's Laboratories Ltd.6.05 %
Cipla Ltd.5.90 %
Lupin Ltd.5.19 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs61.22
Hospital & Healthcare Services24.16
Medical Equipment/Supplies/Accessories3.60
Chemicals3.42
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 03-Feb-2025)252.90286.90281.32444.33537.80
Net Assets(Rs Crores) (as on 03-Feb-2025) 1563.95 1778.29 1589.27 2626.34 3628.03
Scheme Returns(%)(Absolute)73.5112.48-1.8658.8819.96
B'mark Returns(%)(Absolute)NANANANANA
Category Rank39/7548/7557/7614/9012/98

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

SBI Healthcare Opp Fund-Reg(G)Very HighEquity422.096.90(1.66%)NAV As on 04 Feb, 202514-Jul-1999Inception Date3,628.03AUM In Cr.29.31%1Y23.55%3Y27.76%5Y16.50%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.450.48(1.30%)NAV As on 04 Feb, 202513-Jul-2018Inception Date5,320.29AUM In Cr.29.99%1Y23.27%3Y28.49%5Y22.26%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.710.44(1.51%)NAV As on 04 Feb, 202528-Dec-2015Inception Date1,287.45AUM In Cr.24.56%1Y20.02%3Y25.20%5Y12.69%Since Inception
Nippon India Pharma Fund(G)Very HighEquity486.924.71(0.98%)NAV As on 04 Feb, 202505-Jun-2004Inception Date8,160.74AUM In Cr.16.46%1Y18.68%3Y25.21%5Y20.67%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.